Track market-moving stories before they get noisy

All of a sudden, photonics seems to be one of the hottest fields among tech enthusiasts. Optical and photonics technology is massively important for AI applications that must field tremendous data throughput that exceeds the limits of traditional wiring. With photonics, data can be zipped through fiber-optic networks at far higher throughput than copper allows, with the added benefits of low latency and better energy efficiency.

Beyond its applications today, photonics may become even more important in the coming years. The reason for this is that many of the benefits that photonics technology provides to AI applications have the same value for quantum technology. For investors, an alternative to picking up pure-play quantum tech firms like IonQ Inc. NYSE: IONQ—even for all the many reasons these companies may appeal to those with a healthy appetite for risk—is to look at companies making photonics tools that could power next-gen quantum tech down the line.

Get Lumentum alerts:

Lumentum's Major Rally May Pose Valuation Concerns, But Revenue Momentum Is RealLumentum Holdings Inc. NASDAQ: LITE is a photonic technologies firm that got off to a strong start to the year and done a fairly good job of maintaining that momentum. Overall, LITE stock has doubled year to date (YTD), despite some horizontal trading in the last several months.

Lumentum Today

$836.90 +71.35 (+9.32%)

As of 01:33 PM Eastern

This is a fair market value price provided by Massive. Learn more.

52-Week Range$97.55▼

$1,085.68P/E Ratio154.37

Price Target$1,012.67

While the massive rally has not helped alleviate concerns about Lumentum's valuation—the firm currently trades at nearly 142x earnings—analysts are still largely optimistic about its prospects going forward. Two-thirds of the 21 analyst ratings for LITE shares are Buys, and Wall Street anticipates more than 32% more in possible upside to come.

Lumentum's capacity to weather the storm in recent weeks, as AI stocks have taken a hit, is impressive but perhaps not surprising given the massive success the company has seen in recent periods. In the latest quarter, for example, Lumentum boosted revenue by about 90% year over year (YOY) to $808 million, with a strong non-GAAP operating margin coming in at 32.2% as well. Management expects another record quarter, with no signs of slowing sales momentum.

A Smaller Alternative That Has Room to GrowAt a $4-billion market cap, IPG Photonics Corp. NASDAQ: IPGP is just a fraction of the size of the $60-billion behemoth Lumentum, but that doesn't mean investors should overlook this fast-growing alternative. IPGP shares are up about 37% YTD as the firm reported a strong quarter earlier in the year. Q1 2026 revenue was $265 million, a 17% YOY improvement, and bookings improved as well. Adjusted earnings per share (EPS) of 29 cents more than tripled YOY, thanks in large part to the strength of IPG's industrial solutions business.

IPG Photonics Today

$103.30 +5.40 (+5.51%)

As of 01:32 PM Eastern

This is a fair market value price provided by Massive. Learn more.

52-Week Range$71.35▼

$155.82P/E Ratio149.43

Price Target$137.17

IPG has the benefit of multiple angles within the photonics space, and its products and services also cover medical, semiconductor, defense, and other applications. This helps make the firm resilient in the face of sector-wide turmoil, but it doesn't help IPG deal with ongoing tariff headwinds.

Nonetheless, a strong balance sheet including $813 million in cash and short-term investments as of the end of the last quarter should give IPG the necessary runway to continue to support expansion, which will be vital if the firm hopes to compete with larger players in the years to come. With only nine analyst ratings, IPGP shares are not nearly as well covered as rivals like LITE. However, two-thirds of analysts view IPGP stock as a Buy, with about 40% in predicted upside.

A Speculative Play With Big Defense PlansnLight Today

$75.33 +7.03 (+10.28%)

As of 01:32 PM Eastern

This is a fair market value price provided by Massive. Learn more.

52-Week Range$18.51▼

$86.95Price Target$80.94

nLight Inc. NASDAQ: LASR is comparable in size to IPG, though its 100% YTD return outshines its competitor's. This company reported 55% YOY revenue gains in the latest quarter, although at an absolute level, sales were much more modest: nLight saw $80.2 million in revenue for the period. Margins and adjusted EBITDA were also strong, a sign that the company should be able to continue strengthening its balance sheet.

As a pre-profit company, nLight necessarily carries a higher level of risk than the other firms on this list.

Still, a massive new contract with the Pentagon should help to firm up the company's defense-focused business for some time to come. Regardless, investors should view this play as more speculative than other photonics businesses.

That doesn't stop analysts from adopting a bullish viewpoint. LASR has 11 Buy ratings and a single Sell, and analysts see moderate upside even after its sizable rally YTD.

Should You Invest $1,000 in Lumentum Right Now?Before you consider Lumentum, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lumentum wasn't on the list.

While Lumentum currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

IPG Photonics Corporation (IPGP) M&A Call July 17, 2026 8:00 AM EDT

Company Participants

Eugene Fedotoff - Senior Director of Investor Relations
Mark Gitin - CEO & Director
Timothy P.V. Mammen - Senior VP & CFO

Conference Call Participants

Ruben Roy - Stifel, Nicolaus & Company, Incorporated, Research Division
James Ricchiuti - Needham & Company, LLC, Research Division
Michael Feniger - BofA Securities, Research Division
Scott Graham - Seaport Research Partners

Presentation

Operator

Good morning, and welcome to IPG Photonics' conference call to discuss the company's acquisition of Lumibird Medical. Today's call is being recorded and webcast.

At this time, I would like to turn the call over to Eugene Fedotoff, IPG's Senior Director, Investor Relations, for introductions. Please go ahead with your conference.

Eugene Fedotoff
Senior Director of Investor Relations

Thank you, and good morning, everyone. With me today is IPG Photonics' CEO, Dr. Mark Gitin; and Senior Vice President and CFO, Tim Mammen. Today's call will cover IPG's proposed acquisition of Lumibird Medical.

Let me remind you that statements made during this call that discuss our expectations or predictions of the future are forward-looking statements. These forward-looking statements are subject to risks and uncertainties that could cause the company's actual results to differ materially from those projected in such forward-looking statements. These risks and uncertainties are discussed in our Form 10-K for the period ended December 31, 2025, and our reports on file with the Securities and Exchange Commission. Any forward-looking statements made on this call are the company's expectations or predictions as of today, July 17, 2026, only, and the company assumes no obligation to publicly release any updates or revisions to any such statements.

During this call, we will be referring to certain non-GAAP measures, including measures derived from or aligned with IFRS reporting standards as well as other non-GAAP measures. Such

 Creates a Scaled Medical Laser Platform, Accelerating IPG’s Strategic Expansion in Advanced Solutions

Expected to Be Accretive to Gross Margin, EBITDA, and Adjusted EPS

MARLBOROUGH, Mass., July 16, 2026 (GLOBE NEWSWIRE) -- IPG Photonics Corporation (NASDAQ: IPGP) today announced that it has entered into a binding offer to acquire Lumibird Medical. The acquisition advances IPG’s strategy, further expanding the Advanced Solutions portfolio in attractive medical markets. The transaction is expected to deliver financial benefits by adding a high-margin business that is accretive to gross margin, EBITDA and adjusted EPS. IPG believes that the combined medical businesses will create a scaled medical laser platform for growth with complementary established leadership in ophthalmology and urology. The company expects that this also adds approximately $1 billion in addressable market for Advanced Solutions, expanding long-term value creation opportunities that leverage IPG’s capabilities.

IPG intends to acquire Lumibird Medical for a purchase price of €300 million on a cash-free, debt-free basis. The purchase price will be paid in cash at closing. A contingent earnout consideration of up to €50 million additional in cash is based on achieving certain 2026 and 2027 performance metrics. The acquisition will be funded with cash on hand.

“We expect that this acquisition will accelerate our strategic expansion in attractive medical markets in Advanced Solutions,” said Dr. Mark Gitin, IPG Photonics’ Chief Executive Officer. “Lumibird Medical’s leadership in ophthalmology complements our strength in urology, which will create a scaled medical platform with opportunities to accelerate innovation, broaden our commercial reach and deliver differentiated solutions for physicians and patients. We expect the transaction to strengthen our long-term growth profile and provide significant value creation. I am looking forward to welcoming the Lumibird Medical team to IPG.”

“I’m excited about the future of Lumibird Medical, which will benefit significantly from IPG’s scale and leadership in lasers, photonics and applications,” said Jean-Marc Gendre, CEO of Lumibird Medical. “I am convinced that becoming part of IPG will provide our teams, our technologies and our customers with outstanding opportunities to accelerate this remarkable journey while preserving the culture of innovation that has made our success.”

Lumibird Medical is a global leader in diagnostic and treatment systems for ophthalmology, a highly regulated medical laser market that is largely driven by non-discretionary spending. The company designs and produces diagnostic and therapeutic tools for conditions including cataracts, glaucoma, dry eye and age-related macular degeneration, and is a partner of choice for specialist and generalist patient care. Its proprietary laser technology delivers innovative solutions, from diagnosis to laser treatment, through market-leading brands including Quantel Medical, Ellex and Optotek Medical. Headquartered in France, the company has three major global facilities and more than 450 employees worldwide. Lumibird Medical has a track record of sales growth and EBITDA margin expansion. For the fiscal year ended December 31, 2025, Lumibird Medical reported revenue of €112.2 million and EBITDA of €24.1 million with EBITDA margin of 21.5%1.

1 Lumibird Medical's historical financials are prepared under IFRS. Please see the reconciliation from IFRS to U.S. GAAP in the appendix of the presentation furnished with the SEC on Form 8-K.

Transaction Timing

Following completion of the information and consultation process with Lumibird Medical's works council in accordance with French law, the parties expect to enter into a definitive purchase agreement. IPG Photonics expects the transaction to close during the fourth quarter of 2026, subject to customary closing conditions.

Conference Call Details

The Company will hold a conference call tomorrow, July 17, 2026, at 8:00 a.m. ET. To access the call, please dial 877-407-6184 in the US or 201-389-0877 internationally. A live webcast of the call will also be available and archived on the investor relations section of the Company’s website at investor.ipgphotonics.com.

Contact

Eugene Fedotoff
Senior Director, Investor Relations
IPG Photonics Corporation
508-597-4713
[email protected]

About IPG Photonics Corporation

Innovation is at the heart of IPG Photonics. As a global leader in laser technology, we apply light to transform the world. From manufacturing to medical and beyond, our breakthrough laser solutions power our customers’ success and expand what's possible. Discover more at www.ipgphotonics.com.

Safe Harbor Statement

Information and statements provided by IPG and its employees, including statements in this press release, that relate to future plans, events or performance are forward-looking statements within the meaning of the federal securities laws, including the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, each as amended. These statements involve risks and uncertainties. Any statements in this press release that are not statements of historical fact are forward-looking statements, including those statements related to the proposed acquisition of Lumibird Medical (the "Proposed Transaction") and the timing and completion thereof, advancing IPG’s strategy , further expanding the Advanced Solutions portfolio in attractive medical markets, delivering financial benefits by adding a high-margin business, accretive to gross margin, EBITDA and adjusted EPS, the combination creating a scaled platform for growth, adding approximately $1 billion in addressable market, expanding long-term value creation opportunities that leverage IPG’s capabilities, expecting the transaction to provide opportunities to accelerate innovation, broaden commercial reach, deliver differentiated solutions, to strengthen long-term growth profile, provide value creation and to be accretive to margin, EBITDA and adjusted EPS, the ability to complete the information and consultation process with Lumibird Medical's works council, the execution of definitive agreements relating to the Proposed Transaction, the ability to obtain required regulatory approvals and to satisfy other customary closing conditions, the ability to successfully integrate Lumibird Medical's business and retain its employees, customers and distributors, and the realization of anticipated synergies and the expected closing date. Factors that could cause actual results to differ materially include risks and uncertainties, including risks associated with the strength or weakness of business conditions in industries and geographic markets that IPG serves, particularly the effect of downturns in the markets IPG serves; uncertainties and adverse changes in the general economic conditions of markets; inability to manage risks associated with international customers and operations; changes in trade controls and tariff policies; IPG's ability to penetrate new applications for fiber lasers and increase market share; the rate of acceptance and penetration of IPG's products; foreign currency fluctuations; high levels of fixed costs from IPG's vertical integration; the appropriateness of IPG's manufacturing capacity for the level of demand; competitive factors, including declining average selling prices; the effect of acquisitions and investments; inventory write-downs; asset impairment charges; intellectual property infringement claims and litigation; interruption in supply of key components; manufacturing risks; government regulations and trade sanctions; and other risks identified in IPG's SEC filings. There can be no assurance that the Proposed Transaction will be consummated on the anticipated timeline or at all. Readers are encouraged to refer to the risk factors described in IPG's Annual Report on Form 10-K (filed with the SEC on February 23, 2026) and IPG's reports filed with the SEC, as applicable. Actual results, events and performance may differ materially. Readers are cautioned not to rely on the forward-looking statements, which speak only as of the date hereof. IPG undertakes no obligation to update the forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

Use of Non-GAAP Adjusted Financial Information

We refer to certain financial measures that are not recognized under United States generally accepted accounting principles (“GAAP”) and are provided as supplemental information to enhance understanding of the Company’s financial performance. Such non-GAAP financial measures should not be considered superior to, as a substitute for or alternative to, and should be considered in conjunction with, the GAAP financial measure presented by the Company.

March 16, 2026 16:01 ET  | Source: IPG Photonics Corporation

MARLBOROUGH, Mass., March 16, 2026 (GLOBE NEWSWIRE) -- IPG Photonics Corporation (NASDAQ: IPGP), the global leader in fiber laser technology, announced today that the Local Division of the Unified Patent Court (UPC) located in Düsseldorf, Germany has issued a decision in a patent infringement case brought by Trumpf SE & Co. KG (“Trumpf”).

The court ruled that certain uses and designs of IPG’s adjustable mode beam (AMB) lasers infringed European Patent 2,624,031. The decision impacts AMB laser products sold in Germany, France and Italy, affecting less than 1% of IPG’s total sales.

The Company is implementing contingency measures to support AMB customers. Other lasers models made by IPG were not involved in the lawsuit and IPG’s product portfolio remains broadly available. Remedies available to the patent owner, including an injunction, recall and damages, may be enforced and determined at a subsequent time after the required conditions have been satisfied.

IPG respectfully disagrees with the decision and plans to file an appeal with the UPC Court of Appeal and pursue other measures available to it.

IPG previously disclosed that affiliates of Trumpf have brought two separate actions in the Unified Patent Courts in Mannheim, Germany and Düsseldorf, Germany asserting two different patents against IPG’s AMB lasers. IPG previously announced the Mannheim court’s decision and IPG’s intention to appeal. Today’s announcement relates solely to a different patent asserted in the separate Düsseldorf proceeding.

Contact

Eugene Fedotoff
Senior Director, Investor Relations
IPG Photonics Corporation
508-597-4713
[email protected]

About IPG Photonics Corporation

IPG Photonics Corporation is the leader in high-power fiber lasers and amplifiers used primarily in materials processing and other diverse applications. The Company’s mission is to develop innovative laser solutions, making the world a better place. IPG accomplishes this mission by delivering superior performance, reliability, and usability at a lower total cost of ownership compared with other types of lasers and non-laser tools, allowing end users to increase productivity and decrease costs. IPG is headquartered in Marlborough, Massachusetts and has more than 30 facilities worldwide. For more information, visit www.ipgphotonics.com.

Safe Harbor Statement

Information and statements provided by IPG and its employees, including statements in this press release, that relate to future plans, events or performance are forward-looking statements. These statements involve risks and uncertainties. Any statements in this press release that are not statements of historical fact are forward-looking statements, including those related to the percentage of total sales impacted by the decision, remedies available to the patent owner, the enforcement and determination of damages, implementing contingency measures to support AMB customers, and filing an appeal with the UPC Court of Appeals and pursuing other measures available to it. Factors that could cause actual results to differ materially include risks and uncertainties, including risks associated with intellectual property and litigation, and other risks identified in IPG's SEC filings. Readers are encouraged to refer to the risk factors described in IPG's Annual Report on Form 10-K (filed with the SEC on February 23, 2026) and IPG's reports filed with the SEC, as applicable. Actual results, events and performance may differ materially. Readers are cautioned not to rely on the forward-looking statements, which speak only as of the date hereof. IPG undertakes no obligation to update the forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

Posted by Defense World Staff on Mar 30th, 2026

Assenagon Asset Management S.A. acquired a new stake in IPG Photonics Corporation (NASDAQ:IPGP – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 47,981 shares of the semiconductor company’s stock, valued at approximately $3,435,000. Assenagon Asset Management S.A. owned 0.11% of IPG Photonics at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of the stock. Versant Capital Management Inc boosted its position in shares of IPG Photonics by 51.1% in the third quarter. Versant Capital Management Inc now owns 343 shares of the semiconductor company’s stock worth $27,000 after buying an additional 116 shares during the period. Allworth Financial LP raised its holdings in shares of IPG Photonics by 10.2% during the 3rd quarter. Allworth Financial LP now owns 1,449 shares of the semiconductor company’s stock valued at $115,000 after buying an additional 134 shares during the period. PNC Financial Services Group Inc. lifted its position in IPG Photonics by 8.9% during the 2nd quarter. PNC Financial Services Group Inc. now owns 1,813 shares of the semiconductor company’s stock worth $124,000 after acquiring an additional 148 shares in the last quarter. Ballast Asset Management LP lifted its position in IPG Photonics by 0.6% during the 3rd quarter. Ballast Asset Management LP now owns 34,941 shares of the semiconductor company’s stock worth $2,767,000 after acquiring an additional 197 shares in the last quarter. Finally, Orion Porfolio Solutions LLC boosted its holdings in IPG Photonics by 2.8% in the 2nd quarter. Orion Porfolio Solutions LLC now owns 7,922 shares of the semiconductor company’s stock worth $544,000 after acquiring an additional 215 shares during the period. Institutional investors and hedge funds own 93.79% of the company’s stock.

Insider Buying and Selling In other news, Director Eugene A. Scherbakov sold 2,700 shares of the company’s stock in a transaction dated Wednesday, January 21st. The shares were sold at an average price of $80.96, for a total value of $218,592.00. Following the sale, the director owned 59,330 shares in the company, valued at approximately $4,803,356.80. This represents a 4.35% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, major shareholder Fibre Devices Ltd Ip sold 13,381 shares of the stock in a transaction dated Wednesday, January 21st. The stock was sold at an average price of $81.52, for a total transaction of $1,090,819.12. Following the transaction, the insider directly owned 6,593,169 shares in the company, valued at $537,475,136.88. The trade was a 0.20% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 134,617 shares of company stock worth $10,636,883. 39.50% of the stock is currently owned by insiders.

Analyst Ratings Changes Several analysts have issued reports on IPGP shares. Raymond James Financial downgraded shares of IPG Photonics from a “strong-buy” rating to an “outperform” rating and increased their price objective for the company from $97.00 to $180.00 in a research report on Friday, February 13th. Zacks Research raised shares of IPG Photonics from a “hold” rating to a “strong-buy” rating in a research report on Thursday, January 15th. Wall Street Zen downgraded shares of IPG Photonics from a “buy” rating to a “hold” rating in a research note on Sunday. Stifel Nicolaus lifted their price target on shares of IPG Photonics from $92.00 to $165.00 and gave the stock a “buy” rating in a research note on Friday, February 13th. Finally, Roth Mkm boosted their price objective on shares of IPG Photonics from $105.00 to $110.00 and gave the stock a “buy” rating in a report on Tuesday, February 3rd. One investment analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $131.40.

View Our Latest Research Report on IPG Photonics

IPG Photonics Price Performance IPGP stock opened at $115.70 on Monday. The stock’s 50 day moving average is $115.71 and its two-hundred day moving average is $93.05. IPG Photonics Corporation has a 52-week low of $48.59 and a 52-week high of $155.82. The company has a market capitalization of $4.88 billion, a PE ratio of 156.35, a P/E/G ratio of 2.84 and a beta of 0.94.

IPG Photonics (NASDAQ:IPGP – Get Free Report) last released its earnings results on Thursday, February 12th. The semiconductor company reported $0.46 EPS for the quarter, beating the consensus estimate of $0.25 by $0.21. The company had revenue of $274.47 million during the quarter, compared to analysts’ expectations of $249.58 million. IPG Photonics had a return on equity of 2.89% and a net margin of 3.10%.The business’s revenue was up 17.2% on a year-over-year basis. During the same period in the prior year, the business posted $0.18 EPS. IPG Photonics has set its Q1 2026 guidance at 0.100-0.400 EPS. As a group, sell-side analysts anticipate that IPG Photonics Corporation will post 1.54 EPS for the current year.

IPG Photonics Profile (Free Report)

IPG Photonics Corporation is a global leader in the design and manufacture of high-performance fiber lasers and amplifiers used in industrial, medical, scientific, and telecommunications applications. The company’s core products include ytterbium and erbium fiber lasers, diode lasers, and fiber amplifiers that deliver high power and efficiency for precision cutting, welding, marking, and engraving. IPG’s systems are engineered to optimize process speed, reliability, and energy consumption, making them a preferred choice for advanced manufacturing environments.

In addition to stand-alone laser sources, IPG offers turnkey laser systems and integrated solutions tailored to sectors such as automotive, electronics, aerospace, additive manufacturing, and life sciences.

Further Reading Five stocks we like better than IPG Photonics

Receive News & Ratings for IPG Photonics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IPG Photonics and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEAssenagon Asset Management S.A. Acquires 28,373 Shares of Mohawk Industries, Inc. $MHK

NEXT HEADLINE »Assenagon Asset Management S.A. Has $3.52 Million Holdings in Shoals Technologies Group, Inc. $SHLS

Posted by Defense World Staff on Apr 4th, 2026

SG Americas Securities LLC increased its position in IPG Photonics Corporation (NASDAQ:IPGP – Free Report) by 374.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 35,007 shares of the semiconductor company’s stock after buying an additional 27,629 shares during the period. SG Americas Securities LLC owned about 0.08% of IPG Photonics worth $2,507,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of the company. Emerald Mutual Fund Advisers Trust acquired a new position in IPG Photonics in the 3rd quarter valued at $6,645,000. Allianz Asset Management GmbH boosted its holdings in shares of IPG Photonics by 45.2% during the third quarter. Allianz Asset Management GmbH now owns 200,138 shares of the semiconductor company’s stock worth $15,849,000 after purchasing an additional 62,286 shares during the last quarter. Polar Asset Management Partners Inc. grew its position in shares of IPG Photonics by 27.4% in the third quarter. Polar Asset Management Partners Inc. now owns 79,721 shares of the semiconductor company’s stock valued at $6,313,000 after purchasing an additional 17,132 shares during the period. Assenagon Asset Management S.A. acquired a new position in IPG Photonics in the fourth quarter valued at $3,435,000. Finally, Old West Investment Management LLC increased its stake in IPG Photonics by 138.0% in the third quarter. Old West Investment Management LLC now owns 20,842 shares of the semiconductor company’s stock valued at $1,650,000 after purchasing an additional 12,085 shares during the last quarter. Hedge funds and other institutional investors own 93.79% of the company’s stock.

Analyst Upgrades and Downgrades Several equities analysts recently weighed in on IPGP shares. Wall Street Zen downgraded IPG Photonics from a “buy” rating to a “hold” rating in a research report on Sunday, March 29th. Benchmark reaffirmed a “hold” rating on shares of IPG Photonics in a research note on Wednesday, December 10th. Raymond James Financial cut shares of IPG Photonics from a “strong-buy” rating to an “outperform” rating and raised their target price for the stock from $97.00 to $180.00 in a research report on Friday, February 13th. Stifel Nicolaus boosted their target price on shares of IPG Photonics from $92.00 to $165.00 and gave the company a “buy” rating in a report on Friday, February 13th. Finally, Roth Mkm upped their price target on shares of IPG Photonics from $105.00 to $110.00 and gave the stock a “buy” rating in a research report on Tuesday, February 3rd. One analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $131.40.

View Our Latest Stock Report on IPG Photonics

Insider Activity In other IPG Photonics news, Director Eric Meurice sold 750 shares of IPG Photonics stock in a transaction that occurred on Monday, February 2nd. The shares were sold at an average price of $95.00, for a total transaction of $71,250.00. Following the transaction, the director directly owned 22,803 shares of the company’s stock, valued at $2,166,285. The trade was a 3.18% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, major shareholder Valentin Gapontsev Trust I sold 23,029 shares of the stock in a transaction on Tuesday, January 13th. The stock was sold at an average price of $76.98, for a total transaction of $1,772,772.42. Following the completion of the sale, the insider directly owned 6,818,577 shares of the company’s stock, valued at $524,894,057.46. The trade was a 0.34% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 134,617 shares of company stock valued at $10,636,883 over the last quarter. 39.50% of the stock is owned by insiders.

IPG Photonics Stock Performance IPGP stock opened at $113.94 on Friday. The company has a market cap of $4.84 billion, a PE ratio of 153.97, a price-to-earnings-growth ratio of 2.79 and a beta of 1.01. The stock has a 50-day moving average price of $118.65 and a two-hundred day moving average price of $94.00. IPG Photonics Corporation has a 12-month low of $48.59 and a 12-month high of $155.82.

IPG Photonics (NASDAQ:IPGP – Get Free Report) last released its quarterly earnings data on Thursday, February 12th. The semiconductor company reported $0.46 EPS for the quarter, topping analysts’ consensus estimates of $0.25 by $0.21. IPG Photonics had a return on equity of 2.89% and a net margin of 3.10%.The company had revenue of $274.47 million for the quarter, compared to the consensus estimate of $249.58 million. During the same period last year, the business posted $0.18 EPS. The company’s quarterly revenue was up 17.2% compared to the same quarter last year. IPG Photonics has set its Q1 2026 guidance at 0.100-0.400 EPS. Equities analysts forecast that IPG Photonics Corporation will post 1.54 EPS for the current fiscal year.

IPG Photonics Company Profile (Free Report)

IPG Photonics Corporation is a global leader in the design and manufacture of high-performance fiber lasers and amplifiers used in industrial, medical, scientific, and telecommunications applications. The company’s core products include ytterbium and erbium fiber lasers, diode lasers, and fiber amplifiers that deliver high power and efficiency for precision cutting, welding, marking, and engraving. IPG’s systems are engineered to optimize process speed, reliability, and energy consumption, making them a preferred choice for advanced manufacturing environments.

In addition to stand-alone laser sources, IPG offers turnkey laser systems and integrated solutions tailored to sectors such as automotive, electronics, aerospace, additive manufacturing, and life sciences.

Read More Five stocks we like better than IPG Photonics

Receive News & Ratings for IPG Photonics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IPG Photonics and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINESynergy Asset Management LLC Decreases Stock Holdings in Microsoft Corporation $MSFT

NEXT HEADLINE »PayPal Holdings, Inc. $PYPL Shares Sold by Spire Wealth Management

MARLBOROUGH, Mass., April 21, 2026 (GLOBE NEWSWIRE) -- IPG Photonics Corporation (Nasdaq: IPGP) will release its first quarter 2026 financial results before the market opens on Tuesday, May 5, 2026. The Company will hold a conference call to review these results at 10:00 a.m. ET on the same day. To access the call, please dial 877-407-6184 in the United States or 201-389-0877 internationally. A live webcast of the call will also be available and archived in the investor relations section of the Company’s website at investor.ipgphotonics.com.

About IPG Photonics Corporation
IPG Photonics Corporation is the leader in high-power fiber lasers and amplifiers used primarily in materials processing and other diverse applications. The Company’s mission is to develop innovative laser solutions making the world a better place. IPG accomplishes this mission by delivering superior performance, reliability and usability at a lower total cost of ownership compared with other types of lasers and non-laser tools, allowing end users to increase productivity and decrease costs. IPG is headquartered in Marlborough, Massachusetts and has more than 30 facilities worldwide. For more information, visit www.ipgphotonics.com.

Contact:
Eugene Fedotoff
Senior Director, Investor Relations
IPG Photonics Corporation
508-597-4713
[email protected]

Most robotics coverage in the media focuses on the headliners. The humanoid unveil. The next big deployment announcement. While we do cover these newer and “hot” technologies in-depth, it’s important to remember that the majority of innovation and deployment in physical automation continues to happen on the factory floor. 

Below, we highlight six companies in the ROBO Global Robotics and Automation Index (ROBO) that showcase a different side of the robotics story than you often hear in the news. Some have reported recently. Others are reporting soon. Taken together, they span the entire globe and are involved in almost every product you use. These are not companies you normally see trending on X.  

See more: ROBO Index-Linked Assets Double as Investors Pivot to Physical AI

FANUC Corporation (6954.T) If you want to understand industrial robotics, start with FANUC. Founded in 1956 as part of Fujitsu and spun out as an independent company in 1972, FANUC is the company that automated the machines that make the machines. It commands the top global market share in CNC (computerized numerical control) systems and industrial robots, and its yellow machines are embedded in manufacturing facilities across automotive, aerospace, electronics, and more.

In August 2023, it became the first industrial robot manufacturer to ship a cumulative one million robots. Today, with over a million units running factory floors across more than 100 countries, FANUC’s record FY2025 results provide a clear blueprint of where industrial automation capital is flowing.

In its fiscal year ending March 2026, FANUC posted record net sales of JPY 857 billion, up 8% year over year, with operating margin improving 150 basis points to 21.4%. For fiscal 2026, management guided 6% further sales growth and margin expansion to 23.3%. 

The drivers: strong factory automation demand in China and the Americas, and continued investment from customers navigating persistent labor shortages. FANUC’s tariff commentary is notable. After initial capital investment hesitancy, management said companies with sufficient liquidity are now investing again, partly because labor shortages in the U.S. show no sign of easing.

ABB (ABB) ABB is one of the foundational names in industrial automation. The Swiss-headquartered company spans robotics and discrete automation, electrification, process automation, and motion control. Its products are embedded in factories, power grids, data centers, ports, and electric vehicle infrastructure across 100 countries. If FANUC owns the CNC and robot controller layer, ABB owns much of the electrical infrastructure that powers the machines FANUC, and other ROBO constituents in the Manufacturing and Industrial Automation subsector controls.

That context makes its Q1 2026 results worth reading carefully. ABB posted orders of $11.3 billion against a consensus of $9.77 billion, beating it by more than $1.5 billion and up 32% year over year. Revenue grew 18%. Free cash flow hit a Q1 record of $1.3 billion. Management raised full-year guidance, targeting high single-digit to low double-digit revenue growth for 2026. The standout driver: electrification, where data center-related demand grew triple digits.

The same AI infrastructure buildout pulling through demand for Koh Young’s inspection systems and Han’s Laser’s processing equipment is simultaneously driving explosive demand for the electrical switchgear, power distribution, and automation systems that ABB makes. The factories building AI hardware need ABB products to run. The data centers running AI need ABB products to stay powered. Electrification is core to the supply and demand of robotics and AI. 

Han’s Laser (002008.SZ) Han’s Laser is China’s dominant laser processing equipment manufacturer and one of the world’s largest. The company’s machines cut, weld, mark, and process materials across electronics, automotive, new energy, and semiconductor manufacturing. It is the industrial laser equivalent of infrastructure.

Its 2025 annual report, released earlier this month, tells a similar story. Revenue hit $2.67 billion, up 27% year over year, a three-year high. Core operating profit, excluding non-recurring gains, surged 82%. Q4 2025 revenue was up 18.55% quarter over quarter, the fourth consecutive quarter of sequential improvement. The growth drivers tell you exactly where intelligent manufacturing capital is flowing: AI server infrastructure, new energy, and semiconductor domestic substitution across China. Looking ahead, management explicitly called out embodied intelligence as a 2026 opportunity. 

Koh Young Technology (098460.KQ) Most people have never heard of Koh Young. That is a mistake. The South Korean company is the global leader in 3D measurement-based inspection systems. In practice, that means Koh Young’s machines sit on electronics manufacturing lines around the world and verify, with sub-micron precision, that every solder joint, every component placement, and every semiconductor package is exactly where it should be. No inspection, no yield. No yield, no product.

Last week, Koh Young reported Q1 2026 results that deserve more attention than they got. Revenue of 72.7 billion won was up 42% year over year, a record first quarter. Operating profit jumped 209%. Net profit jumped 389%. The growth came from two simultaneous drivers: expanded sales of 3D semiconductor packaging inspection equipment to what the company described as a global No.1 AI data center optical communications module customer, and surging demand for its AI smart factory software across the same customer base. Both pillars grew at the same time. The company said that dynamic is exactly what they expect to continue.

IPG Photonics (IPGP) IPG Photonics (IPGP) invented the modern fiber laser. The Massachusetts-based company builds the high-power laser sources that sit inside cutting, welding, and materials processing systems across manufacturing globally. Where Han’s Laser makes the machine, IPG makes the engine inside the machine.

IPG does not report Q1 2026 until May 5, but its Q4 2025 results, released in February, made clear the recovery is real. Revenue of $274.5 million was up 17.2% year over year, beating consensus by a wide margin. The stock jumped over 35% on that print. Management guided Q1 2026 revenue of $235 to $265 million, acknowledging ongoing tariff uncertainty. The underlying demand driver is the same one running through this entire piece: manufacturers building out AI infrastructure, new energy capacity, and precision automation are buying more laser processing equipment. As a bonus, they are now seeing new demand from utilization in medical and even counter-drone technology that feels a bit like Star Wars.

Microchip Technology (MCHP) Microchip Technology (MCHP) is the backbone of embedded control in industrial robotics. Its microcontrollers, FPGAs, and analog chips are inside motor drives, robotic arms, sensors, and automation controllers across the industrial stack. When a robot moves, there is often a Microchip part deciding how.

Microchip spent most of 2024 and the first half of 2025 working through one of the worst inventory corrections in the semiconductor industry, which appears to have escaped from the bottom. In Q3 fiscal 2026 (the quarter ended December 31, 2025), revenue hit $1.186 billion, up 15.6% year over year and well above guidance. Non-GAAP gross margins recovered from 52% at the trough to 60.5%. Management guided Q4 fiscal 2026 revenue of approximately $1.26 billion at the midpoint, up 29.8% year over year. CEO Steve Sanghi called it a broad-based recovery across end markets, with industrials leading. 

Robotics Ecosystem Takeaways  These six companies touch different parts of the robotics and automation stack. CNC and robot controllers. Electrical infrastructure and power systems. Laser processing and materials manufacturing. Precision inspection. Embedded semiconductors. Precise robot arms and manipulation. 

Capital is coming back into industrial automation. The AI infrastructure buildout is pulling through demand for intelligent manufacturing equipment, not just data center hardware. Labor economics are reinforcing the automation case in the Americas and across Asia. Electrification is the connective tissue binding it all together. And companies that held margins through the cycle are now positioned to expand them as volumes return.

The continued march of Robotics as a fundamental part of our modern world has been the thesis since the inception of the ROBO Index back in 2013. What is clarifying right now is the breadth of confirmation. Across the world, the same buildout is showing up in orders, revenue, margins, and guidance. 

The factory floor is speaking, are you listening? 

ROBO is the underlying index for the ROBO Global Robotics & Automation ETF (ROBO), the L&G ROBO Global Robotics and Automation UCITS ETF (ROBO.LN), and the Global X ROBO Global Robotics & Automation ETF (ROBO.AU).  

Looking for regular updates? Subscribe here for weekly insights on robotics, AI, and healthcare technology, delivered straight to your inbox.

For more news, information, and analysis, visit our Artificial Intelligence & Disruptive Technology Content Hubs.

VettaFi is the index provider for ROBO ETFs, for which it receives an index licensing fee. However, ROBO ETFs are not issued, sponsored, endorsed, or sold by VettaFi. VettaFi and its affiliates have no obligation or liability in connection with the issuance, administration, marketing, or trading of ROBO ETFs. 

U.S. Fund A Shares (without sales charge*) posted a return of 1.17% in first quarter 2026. Leading contributors in the First Eagle U.S. Fund this quarter included gold bullion, Exxon Mobil Corporation, Noble Corporation PLC Class A, IPG Photonics Corporation and SLB Limited. The leading detractors in the quarter were Workday, Inc. Class A, Oracle Corporation, Salesforce.com, Inc., Meta Platforms, Inc. Class A and Universal Health Services, Inc, Class B.

 Strong Start to the Year on Growing Demand and Continued Focus on Execution of Strategic Initiatives

Managing Costs and Mitigating Tariff Impact on Gross Margin

MARLBOROUGH, Mass., May 05, 2026 (GLOBE NEWSWIRE) -- IPG Photonics Corporation (NASDAQ: IPGP) today reported financial results for the first quarter ended March 31, 2026.

  Three Months Ended March 31,(In millions, except per share data and percentages)  2026   2025  ChangeRevenue $265.5  $227.8  17%Gross margin  37.5%  39.4%  Operating income (loss) $(7.7) $1.8  NMOperating margin (2.9)%  0.8%  Net income $1.6  $3.8  (58)%Earnings per diluted share $0.04  $0.09  (56)%Non-GAAP Measures*      Adjusted gross margin  37.8%  40.0%  Adjusted EBITDA $35.2  $32.7  8%Adjusted earnings per diluted share $0.29  $0.31  (6)%
*Adjusted gross margin, adjusted EBITDA and adjusted earnings per diluted share include non-GAAP adjustments. A reconciliation from GAAP to non-GAAP metrics is provided in this earnings release.

NM - not meaningful.

Management Comments

“I am pleased to share that first-quarter revenue came in above our expectations. The team delivered our second consecutive quarter of double-digit year-over-year revenue growth, driven by disciplined execution of our key strategic initiatives and continued strong demand for our laser solutions,” said Dr. Mark Gitin, Chief Executive Officer of IPG Photonics.

Financial Highlights

Beginning in the first quarter, the Company revised its revenue disaggregation by application into two categories: Industrial Solutions and Advanced Solutions. This structure better reflects the Company's strategic growth initiatives and provides a clearer separation between the Company's industrial and non-industrial businesses, giving better visibility into the distinct performance and growth profiles of each.

 Three Months Ended March 31, 2026
 2025
 ChangeSales by Application     Industrial Solutions$227,590 $188,016 21%Advanced Solutions 37,907  39,777 (5)%Total$265,497 $227,793 17%
First quarter revenue of $265 million increased 17% year over year, driven by growth in Industrial Solutions. Changes in foreign exchange rates increased revenue growth by approximately 4%. Industrial Solutions sales accounted for 86% of total revenue and increased 21% year over year, driven by growth in welding, cutting, marking, and cleaning applications. Advanced Solutions sales decreased 5% year over year due to lower revenue in micromachining and defense applications, partially offset by increased sales in medical and semiconductor applications. Emerging growth products accounted for 53% of total revenue, consistent with the prior quarter. By region, sales increased 14% in Asia, 27% in North America, and 4% in Europe on a year-over-year basis.

GAAP gross margin of 37.5% and adjusted gross margin of 37.8% decreased year over year due to tariffs and higher product cost, partially offset by lower inventory provisions. Adjusted EBITDA was $35.2 million and adjusted earnings per diluted share (EPS) was $0.29 in the first quarter. During the first quarter, IPG spent $16 million on capital expenditures.

Business Outlook and Financial Guidance

“Our book-to-bill was once again firmly above one in the first quarter, reflecting robust demand for our solutions despite elevated macroeconomic uncertainty. We remain focused on executing on our growth strategy supported by operational excellence and an innovation engine that is unlocking areas of significant additional opportunities. This foundation gives us confidence in our ability to achieve above-market growth and deliver lasting value for our customers and shareholders.” concluded Dr. Gitin.

For the second quarter of 2026, IPG expects revenue of $260 million to $290 million, adjusted gross margin between 37% and 40% and adjusted operating expenses of $92 million to $95 million. IPG anticipates delivering adjusted earnings per diluted share in the range of $0.25 to $0.55 and adjusted EBITDA in the range of $32 million to $48 million.

As discussed in more detail in the "Safe Harbor" passage of this news release, actual results may differ from this guidance due to various factors including, but not limited to, trade policy changes and trade restrictions, product demand, order cancellations and delays, competition, tariffs and retaliatory tariffs, currency fluctuations and general economic conditions. The current uncertainty related to the trade environment and tariff policies increases the risks to the outlook that we have provided. This guidance is based upon current market conditions and expectations, and is subject to the risks outlined in the Company's reports filed with the SEC, and assumes exchange rates relative to the U.S. dollar of euro 0.87, Japanese yen 159 and Chinese yuan 6.92, respectively.

Supplemental Financial Information

Additional supplemental financial information is provided in the unaudited Financial Data Workbook and First Quarter 2026 Earnings Call Presentation available on the investor relations section of the Company's website at investor.ipgphotonics.com.

Conference Call Reminder

The Company will hold a conference call today, May 5, 2026 at 10:00 am ET. To access the call, please dial 877-407-6184 in the US or 201-389-0877 internationally. A live webcast of the call will also be available and archived on the investor relations section of the Company's website at investor.ipgphotonics.com.

Contact

Eugene Fedotoff
Senior Director, Investor Relations
IPG Photonics Corporation
508-597-4713
[email protected]

About IPG Photonics Corporation

IPG Photonics Corporation is the leader in high-power fiber lasers and amplifiers used primarily in materials processing and other diverse applications. The Company’s mission is to develop innovative laser solutions, making the world a better place. IPG accomplishes this mission by delivering superior performance, reliability, and usability at a lower total cost of ownership compared with other types of lasers and non-laser tools, allowing end users to increase productivity and decrease costs. IPG is headquartered in Marlborough, Massachusetts and has more than 30 facilities worldwide. For more information, visit www.ipgphotonics.com.

Safe Harbor Statement

Information and statements provided by IPG and its employees, including statements in this press release, that relate to future plans, events or performance are forward-looking statements. These statements involve risks and uncertainties. Any statements in this press release that are not statements of historical fact are forward-looking statements, including those statements related to operational excellence, an innovation engine that is unlocking areas of significant additional opportunities, and the ability to achieve above-market growth and deliver lasting value for our customers and shareholders, and statements related to shares repurchases, revenue, adjusted gross margin and operating expenses outlook, adjusted earnings per diluted share and adjusted EBITDA guidance, including the expected impact of tariffs, and the impact of the U.S. dollar on our guidance for the second quarter of 2026. Factors that could cause actual results to differ materially include risks and uncertainties, including risks associated with the strength or weakness of business conditions in industries and geographic markets that IPG serves, particularly the effect of downturns in the markets IPG serves; uncertainties and adverse changes in the general economic conditions of markets; inability to manage risks associated with international customers and operations; changes in trade controls and tariff policies; IPG's ability to penetrate new applications for fiber lasers and increase market share; the rate of acceptance and penetration of IPG's products; foreign currency fluctuations; high levels of fixed costs from IPG's vertical integration; the appropriateness of IPG's manufacturing capacity for the level of demand; competitive factors, including declining average selling prices; the effect of acquisitions and investments; inventory write-downs; asset impairment charges; intellectual property infringement claims and litigation; interruption in supply of key components; manufacturing risks; government regulations and trade sanctions; and other risks identified in IPG's SEC filings. Readers are encouraged to refer to the risk factors described in IPG's Annual Report on Form 10-K (filed with the SEC on February 23, 2026) and IPG's reports filed with the SEC, as applicable. Actual results, events and performance may differ materially. Readers are cautioned not to rely on the forward-looking statements, which speak only as of the date hereof. IPG undertakes no obligation to update the forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

IPG PHOTONICS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(UNAUDITED)
   Three Months Ended March 31,   2026  2025
  (In thousands, except per share data)Net sales $265,497  $227,793Cost of sales  165,998   137,981Gross profit  99,499   89,812Operating expenses:    Sales and marketing  24,534   24,430Research and development  33,309   28,336General and administrative  36,092   32,808Settlement of litigation matters  13,500   —(Gain) loss on foreign exchange  (200)  2,411Total operating expenses  107,235   87,985Operating (loss) income  (7,736)  1,827Other income, net:    Interest income, net  6,922   7,444Other income, net  1,833   1,344Total other income  8,755   8,788Income before provision for income taxes  1,019   10,615(Benefit) provision for income taxes  (565)  6,857Net income $1,584  $3,758Net income per common share:    Basic $0.04  $0.09Diluted $0.04  $0.09Weighted average common shares outstanding:    Basic  42,245   42,605Diluted  42,912   42,832 IPG PHOTONICS CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(UNAUDITED)
   March 31, December 31,   2026   2025   (In thousands, except share and
per share data)ASSETSCurrent assets:    Cash and cash equivalents $480,761  $403,790 Short-term investments  332,144   435,538 Accounts receivable, net  192,437   181,734 Inventories  319,006   313,416 Prepaid income taxes  51,203   43,196 Prepaid expenses and other current assets  57,587   45,766 Total current assets  1,433,138   1,423,440 Long-term investments  70,567   76,533 Deferred income taxes, net  120,934   123,889 Goodwill  70,913   71,735 Intangible assets, net  47,171   49,933 Property, plant and equipment, net  636,242   637,516 Other assets  42,677   41,234 Total assets $2,421,642  $2,424,280 LIABILITIES AND EQUITYCurrent liabilities:    Accounts payable $54,724  $39,288 Accrued expenses and other current liabilities  184,849   184,849 Income taxes payable  7,603   9,900 Total current liabilities  247,176   234,037 Other long-term liabilities and deferred income taxes  58,671   62,113 Total liabilities  305,847   296,150 Commitments and contingencies    IPG Photonics Corporation equity:    Common stock, $0.0001 par value, 175,000,000 shares authorized; 57,281,253 and 42,443,381 shares issued and outstanding, respectively, at March 31, 2026; 56,964,939 and 42,127,067 shares issued and outstanding, respectively, at December 31, 2025.  6   6 Treasury stock, at cost, 14,837,872 shares held at March 31, 2026 and December 31, 2025, respectively.  (1,555,629)  (1,555,629)Additional paid-in capital  1,075,709   1,077,172 Retained earnings  2,646,548   2,644,964 Accumulated other comprehensive loss  (50,839)  (38,383)Total stockholders' equity  2,115,795   2,128,130 Total liabilities and stockholders' equity $2,421,642  $2,424,280  IPG PHOTONICS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
   Three Months Ended March 31,   2026   2025   (In thousands)Cash flows from operating activities:    Net income $1,584  $3,758 Adjustments to reconcile net income to net cash (used in) provided by operating activities:    Depreciation and amortization  15,892   15,341 Provisions for inventory, warranty & bad debt  9,348   11,876 Other  11,425   14,796 Changes in assets and liabilities that (used) provided cash:    Accounts receivable and accounts payable  5,438   1,378 Inventories  (19,417)  (8,967)Other  (29,733)  (24,737)Net cash (used in) provided by operating activities  (5,463)  13,445 Cash flows from investing activities:    Purchases of and deposits on property, plant and equipment  (16,311)  (24,818)Proceeds from sales of property, plant and equipment  812   183 Purchases of investments  (32,870)  (333,009)Proceeds from maturities of investments  143,538   83,206 Other  77   52 Net cash provided by (used in) investing activities  95,246   (274,386)Cash flows from financing activities:    Payments for taxes related to net share settlement of equity awards less proceeds from issuance of common stock under employee stock option plans  (11,712)  (5,775)Purchase of treasury stock net of excise tax, at cost  —   105 Net cash used in financing activities  (11,712)  (5,670)Effect of changes in exchange rates on cash and cash equivalents  (1,100)  9,617 Net increase (decrease) in cash and cash equivalents  76,971   (256,994)Cash and cash equivalents — Beginning of period  403,790   620,040 Cash and cash equivalents — End of period $480,761  $363,046 Supplemental disclosures of cash flow information:    Cash paid for interest $3  $5 Cash paid for income taxes, net of refunds $7,689  $10,574 
IPG PHOTONICS CORPORATION
SUPPLEMENTAL SCHEDULE OF NON-GAAP FINANCIAL MEASURES (UNAUDITED)

Use of Non-GAAP Adjusted Financial Information

We refer to certain financial measures that are not recognized under United States generally accepted accounting principles (“GAAP”) and are provided as supplemental information to enhance understanding of the Company’s financial performance. These measures should not be considered as a substitute for, or superior to, GAAP financial measures. The following information provides the definition of adjusted gross profit, adjusted gross margin, adjusted operating income, EBITDA, adjusted EBITDA, adjusted net income, adjusted net earnings per share (EPS), and adjusted tax rate as presented, which are financial measures that are not calculated or presented in accordance with GAAP, and reconciliation to the most directly comparable financial measures calculated and presented in accordance with GAAP. The Company has provided adjusted gross profit, adjusted gross margin, adjusted operating income, EBITDA, adjusted EBITDA, adjusted net income, adjusted EPS, and an adjusted tax rate as supplemental information and in addition to the financial measures presented by the Company that are calculated and presented in accordance with GAAP. Such non-GAAP financial measures should not be considered superior to, as a substitute for or alternative to, and should be considered in conjunction with, the GAAP financial measure presented by the Company.

We define adjusted gross profit as reported gross profit, adjusted for non-recurring, infrequent, or unusual changes, including acquisition and integration charges and amortization of acquisition-related intangibles.

We define adjusted gross margin as adjusted gross profit divided by total revenue.

We define adjusted operating income as reported income from operations, adjusted for non-recurring, infrequent, or unusual charges, including acquisition and integration charges, amortization of acquisition-related intangibles, foreign exchange gains/losses and gain/loss on disposal of assets/divestiture.

We define EBITDA as net income plus interest expense (income), provision for income taxes, depreciation expense, and amortization expense.

We define adjusted EBITDA as EBITDA adjusted for non-recurring, infrequent, or unusual charges, and other adjustments that the Company believes appropriate, including stock-based compensation, acquisition and integration charges, foreign exchange gains/losses and gain/loss on disposal of assets/divestiture.

We define adjusted net income as reported net income, adjusted for non-recurring, infrequent, or unusual changes, and other adjustments that the Company believes appropriate, including amortization of acquisition-related intangibles, acquisition and integration charges, foreign exchange gains/losses and gain/loss on disposal of assets/divestiture, certain discrete tax items and non-GAAP income tax reconciling adjustments.

We define adjusted EPS as adjusted net income divided by the weighted-average diluted shares outstanding.

We define adjusted tax rate as the GAAP tax rate, adjusted for discrete tax items and the net impact of non-GAAP adjustments.

Management believes that these non-GAAP financial measures provide additional means of evaluating period-over-period operating performance. Specifically, these non-GAAP financial measures provide management with additional means to understand and evaluate the operating results and trends in our ongoing business by eliminating certain non-cash expenses and other items that management believes might otherwise make comparisons of our ongoing business with prior periods more difficult, obscure trends in ongoing operations, or reduce management’s ability to make useful forecasts.

In addition, management understands that some investors and financial analysts find this information helpful in analyzing our financial and operational performance and comparing this performance to our peers and competitors. However, these non-GAAP financial measures have limitations as an analytical tool and are not intended to be an alternative to financial measures prepared in accordance with GAAP. In addition, it should be noted that these non-GAAP financial measures may be different from non-GAAP measures used by other companies. Management may, however, utilize other measures to illustrate performance in the future. Investors are encouraged to review the reconciliation of these non-GAAP measures to their most directly comparable GAAP financial measures. A reconciliation of our non-GAAP financial measures to their most directly comparable GAAP measures has been provided below. These non-GAAP measures exclude (i) special inventory provisions, (ii) amortization of acquisition-related intangibles, (iii) restructuring charges, (iv) acquisition and integration costs, (v) goodwill and intangible asset impairments, (vi) long-lived asset impairments and accelerated depreciation of certain long-lived assets, (vii) foreign exchange gains/losses, (viii) interest income, (ix) benefit (provision) from income taxes, (x) depreciation, (xi) amortization, (xii) stock-based compensation, (xiii) gain/loss on disposal of assets/divestiture, (xiv) settlement and fees of litigation matters (xv) certain discrete tax items, and (xvi) non-GAAP income tax reconciling adjustments.

We have not provided a quantitative reconciliation of forward-looking Non-GAAP adjusted earnings per diluted share and adjusted EBITDA to their most directly comparable GAAP financial measures because we are unable to estimate with reasonable certainty the ultimate timing or amount of certain significant items without unreasonable efforts. This is due to the inherent difficulty of forecasting the timing and/or amount of various items that would impact adjusted earnings per diluted share and adjusted EBITDA. This includes items that have not yet occurred, are out of the Company’s control, cannot be reasonably predicted and/or for which there would not be any meaningful adjustment or difference. For the same reasons, the Company is unable to address the probable significance of the unavailable information.

Our non-GAAP tax provision for the fiscal first quarter of 2026 is 30%. The difference between our GAAP income tax provision and our non-GAAP income tax provision is presented as non-GAAP income tax reconciling adjustments.

IPG PHOTONICS CORPORATION
SUPPLEMENTAL SCHEDULE OF NON-GAAP MEASUREMENTS (UNAUDITED)

Reconciliation of Gross Profit to Adjusted Gross Profit, Adjusted Gross Margin
   Three Months Ended March 31,   2026   2025   (in thousands, except percentages)Gross profit $99,499  $89,812 Gross margin  37.5%  39.4%Amortization of acquisition-related intangibles  852   1,016 Acquisition and integration charges  —   222 Adjusted gross profit $100,351  $91,050 Adjusted gross margin  37.8%  40.0% Reconciliation of Operating income (loss) to Adjusted Operating Income
   Three Months Ended March 31,   2026  2025
  (in thousands)Operating (loss) income $(7,736) $1,827Amortization of acquisition-related intangibles  2,089   2,502Restructuring charges  66   —Acquisition and integration charges  906   991Settlement and fees of litigation matters  14,128   —(Gain) loss on foreign exchange  (200)  2,411Adjusted operating income $9,253  $7,731 Reconciliation of Net income to Adjusted EBITDA
   Three Months Ended March 31,   2026   2025   (in thousands)Net income $1,584  $3,758 Interest income, net  (6,922)  (7,444)Provision for income taxes  (565)  6,857 Depreciation  12,747   11,556 Amortization  3,145   3,785 EBITDA $9,989  $18,512 Stock based compensation  10,341   10,767 Restructuring charges  66   — Acquisition and integration charges  906   991 Settlement and fees of litigation matters  14,128   — (Gain) loss on foreign exchange  (200)  2,411 Adjusted EBITDA $35,230  $32,681  Reconciliation of GAAP to Non-GAAP Net Income, and GAAP to Non-GAAP Net Income per Share, Diluted
     Three Months Ended March 31,   2026   2025   (in thousands, except per share data)Net income $1,584  $3,758 Amortization of acquisition-related intangibles  2,089   2,502 Restructuring charges  66   — Acquisition and integration charges  906   991 Settlement and fees of litigation matters  14,128   — (Gain) loss on foreign exchange  (200)  2,411 Certain discrete tax items  (1,119)  4,614 Tax impact of non-GAAP adjustments  (4,873)  (1,148)Adjusted net income $12,581  $13,128 Adjusted net earnings per diluted share $0.29  $0.31 Weighted average diluted shares outstanding  42,912   42,832  Reconciliation of GAAP to Non-GAAP Effective Tax Rate
   Three Months Ended March 31,  2026
 2025
Tax rate (55)% 65%
Discrete tax items 110%
 (43)%Net impact of non-GAAP adjustments (25)% (1)%Adjusted tax rate 30%
 21%

Laser company IPG Photonics (IPGP +2.26%) stock got blasted for a 24.8% loss through 11:45 a.m. ET Tuesday morning despite beating on in its Q1 earnings report.

Heading into the report, analysts forecast IPG to earn $0.27 per share (pro forma) on $256.5 million in sales. In fact, IPG earned $0.29 per share on $265.5 million in sales.

Image source: Getty Images.

IPG Photonics Q1 earnings Not all the news was good.

IPG grew sales an impressive 17% year over year, but profitability declined due to tariff costs. Gross profit margin dropped nearly two percentage points to 37.5%, pushing IPG into an operating loss. Interest on savings and "other" income helped even things out, but IPG's GAAP net profit of $0.04 per share was a whole lot less than the $0.29 per share pro forma profit noted above.

It was also more than 50% less than last year's Q1 profit.

Today's Change

(

2.26

%) $

2.51

Current Price

$

113.70

What's next for IPG Photonics stock? Turning to guidance, IPO highlighted a book-to-bill ratio 1.0, indicating "robust demand for our solutions" and suggesting further sales growth ahead. In Q2, management forecasts sales between $260 million and $290 million, some improvement in gross margin on those sales, and pro forma profit between $0.25 to $0.55.

The bad news? While IPG's sales target looks fine and in line with analyst expectations, Wall Street was hoping IPG would promise $0.43 per share in profit -- and the midpoint of a range stretching from $0.25 to $0.55 is only $0.40 per share.

It's likely to be a small Q2 miss, but it's still a bigger miss than the Q1 beat. For a stock trading for 167 times earnings, it's too big for investors to forgive -- and that's why they're selling IPG Photonics stock today.

Rich Smith has no position in any of the stocks mentioned. The Motley Fool recommends IPG Photonics. The Motley Fool has a disclosure policy.

Key Takeaways IPGP Q1 revenues rose 16.5% to $265.5M, but adjusted EPS fell 6% to 29 cents.Industrial Solutions made 86% of IPGP sales, up 21% y/y, with emerging growth products at 53%.IPG Photonics sees Q2 revenues of $260M-$290M; tariffs to cut adjusted gross margin by 150 bps. IPG Photonics (IPGP - Free Report) reported first-quarter 2026 adjusted earnings of 29 cents per share, which missed the Zacks Consensus Estimate by 9.4% and decreased 6% year over year.

Revenues of $265.5 million increased 16.5% year over year and beat the consensus mark by 3.9%. Emerging growth products accounted for 53% of total revenue in the quarter.

IPGP Revenue Mix Tilts Toward Industrial SolutionsIPGP’s first-quarter growth was driven by improved demand in Industrial Solutions. Industrial Solutions revenues were $227.6 million, representing 86% of total sales and rising 21% year over year, supported by higher revenues in welding, cutting, marking and cleaning applications.

Advanced Solutions revenues were $37.9 million, down 5% year over year. Management noted that growth in medical and semiconductor applications was offset by lower micromachining sales tied to cyclical demand in solar cell manufacturing, alongside lower defense revenue.

IPG Photonics Benefits From Battery And Medical DemandWithin Industrial Solutions, IPG Photonics highlighted continued strength in battery manufacturing demand, which supported results in welding and cutting. The company also pointed to progress in expanding system-level offerings, an area it said is helping IPGP move up the value chain by integrating fiber lasers into complete solutions across applications like welding and cleaning.

In Advanced Solutions, IPG Photonics emphasized traction in medical and semiconductor markets. Medical revenues grew significantly year over year, aided by sales to a new customer, and the company expects several new product approvals and introductions across 2026 and 2027. Semiconductor revenue also improved as IPG ramps new business in lithography, metrology and inspection with large equipment manufacturers.

IPGP Margins Hit by Tariffs Despite Inventory ImprovementsProfitability reflected a mix of operational progress and external cost pressure. GAAP gross margin was 37.5% versus 39.4% in the year-ago quarter, while adjusted gross margin was 37.8% compared with 40% a year ago. Management attributed the year-over-year decline primarily to tariffs and higher product costs, partially offset by lower inventory provisions tied to improved inventory management.

Sequentially, both GAAP and adjusted gross margins improved, benefiting from improved absorption and lower inventory provisions. The company reiterated its focus on pricing and cost-reduction initiatives to support margin improvement, while noting that underabsorbed expenses remain higher than targeted in the medium term.

Operating expenses were impacted by a significant one-time item. Total GAAP operating expenses were $107.2 million, which included a $13.5 million settlement payment and license related to an agreement with TRUMPF Laser- und Systemtechnik, settling all parts of litigation worldwide. Excluding the settlement payment, litigation expenses, amortization and acquisition-related expenses, adjusted operating expenses were approximately $91 million.

GAAP operating loss was $7.7 million in the reported quarter, compared with operating income of $1.8 million in the year-ago quarter. On an adjusted basis, operating income was $9.3 million, up 21% year over year, highlighting that the primary variance in GAAP profitability was tied to non-recurring items.

IPGP Maintains Strong Liquidity and a Debt-Free Balance SheetIPGP ended the first quarter with $813 million in cash and short-term investments, plus $71 million in long-term investments, and no debt. Inventories stood at $319 million, while days sales outstanding were 65.

Cash used in operations was $5.5 million in the first quarter, a period management described as typically weaker for cash generation due to annual bonus payments. Capital expenditures were $16.3 million, reflecting the timing of investments in the company’s major fiber manufacturing facility in Germany.

IPG Photonics Issues Q2 View and Flags Tariff ImpactFor the second quarter of 2026, IPG Photonics expects revenues of $260 million to $290 million. Adjusted gross margin is projected between 37% and 40%, including an estimated tariff-related impact of about 150 basis points.

The company guided adjusted operating expenses of $92 million to $95 million and expects adjusted earnings between 25 cents and 55 cents per share. Adjusted EBITDA is expected to be between $32 million and $48 million, with management noting a cautiously optimistic stance that assumes a generally stable operating environment.

Zacks Rank & Stocks to ConsiderIPG Photonics currently has a Zacks Rank #3 (Hold).

Some better-ranked stocks in the broader Zacks Computer and Technology sector that are set to report their quarterly results are Docebo (DCBO - Free Report) , Diodes (DIOD - Free Report) and Keysight Technologies (KEYS - Free Report) . Each of the three stocks carries a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.

Diodes, Docebo and Keysight Technologies are set to report their quarterly results on May 7, 8 and 19, respectively. Year to date, shares of Diodes and Keysight Technologies have jumped 128% and 75.2%, respectively, while Docebo has dropped 8.4%.

It has been about a month since the last earnings report for IPG Photonics (IPGP - Free Report) . Shares have added about 19.3% in that time frame, outperforming the S&P 500.

But investors have to be wondering, will the recent positive trend continue leading up to its next earnings release, or is IPG due for a pullback? Well, first let's take a quick look at the most recent earnings report in order to get a better handle on the recent catalysts for IPG Photonics Corporation before we dive into how investors and analysts have reacted as of late.

IPGP Q1 Earnings Miss Estimates, Strong Industrial Growth Aids RevenueIPG Photonics reported first-quarter 2026 adjusted earnings of 29 cents per share, which missed the Zacks Consensus Estimate by 9.4% and decreased 6% year over year. 

Revenues of $265.5 million increased 16.5% year over year and beat the consensus mark by 3.9%. Emerging growth products accounted for 53% of total revenue in the quarter.

IPGP Revenue Mix Tilts Toward Industrial SolutionsIPGP’s first-quarter growth was driven by improved demand in Industrial Solutions. Industrial Solutions revenues were $227.6 million, representing 86% of total sales and rising 21% year over year, supported by higher revenues in welding, cutting, marking, and cleaning applications.

Advanced Solutions' revenues were $37.9 million, down 5% year over year. Management noted that growth in medical and semiconductor applications was offset by lower micromachining sales tied to cyclical demand in solar cell manufacturing, alongside lower defense revenue.

IPG Photonics Benefits From Battery And Medical DemandWithin Industrial Solutions, IPG Photonics highlighted continued strength in battery manufacturing demand, which supported results in welding and cutting. The company also pointed to progress in expanding system-level offerings, an area it said is helping IPGP move up the value chain by integrating fiber lasers into complete solutions across applications like welding and cleaning.

In Advanced Solutions, IPG Photonics emphasized traction in medical and semiconductor markets. Medical revenues grew significantly year over year, aided by sales to a new customer, and the company expects several new product approvals and introductions across 2026 and 2027. Semiconductor revenue also improved as IPG ramps new business in lithography, metrology, and inspection with large equipment manufacturers.

IPGP Margins Hit by Tariffs Despite Inventory ImprovementsProfitability reflected a mix of operational progress and external cost pressure. GAAP gross margin was 37.5% versus 39.4% in the year-ago quarter, while adjusted gross margin was 37.8% compared with 40% a year ago. Management attributed the year-over-year decline primarily to tariffs and higher product costs, partially offset by lower inventory provisions tied to improved inventory management.

Sequentially, both GAAP and adjusted gross margins improved, benefiting from improved absorption and lower inventory provisions. The company reiterated its focus on pricing and cost-reduction initiatives to support margin improvement, while noting that underabsorbed expenses remain higher than targeted in the medium term.

Operating expenses were impacted by a significant one-time item. Total GAAP operating expenses were $107.2 million, which included a $13.5 million settlement payment and license related to an agreement with TRUMPF Laser- und Systemtechnik, settling all parts of litigation worldwide. Excluding the settlement payment, litigation expenses, amortization, and acquisition-related expenses, adjusted operating expenses were approximately $91 million.

GAAP operating loss was $7.7 million in the reported quarter, compared with operating income of $1.8 million in the year-ago quarter. On an adjusted basis, operating income was $9.3 million, up 21% year over year, highlighting that the primary variance in GAAP profitability was tied to non-recurring items.

IPGP Maintains Strong Liquidity and a Debt-Free Balance SheetIPGP ended the first quarter with $813 million in cash and short-term investments, plus $71 million in long-term investments, and no debt. Inventories stood at $319 million, while days sales outstanding were 65.

Cash used in operations was $5.5 million in the first quarter, a period management described as typically weaker for cash generation due to annual bonus payments. Capital expenditures were $16.3 million, reflecting the timing of investments in the company’s major fiber manufacturing facility in Germany.

IPG Photonics Issues Q2 View and Flags Tariff ImpactFor the second quarter of 2026, IPG Photonics expects revenues of $260 million to $290 million. Adjusted gross margin is projected between 37% and 40%, including an estimated tariff-related impact of about 150 basis points.

The company guided adjusted operating expenses of $92 million to $95 million and expects adjusted earnings between 25 cents and 55 cents per share. Adjusted EBITDA is expected to be between $32 million and $48 million, with management noting a cautiously optimistic stance that assumes a generally stable operating environment.

How Have Estimates Been Moving Since Then?It turns out, estimates revision have trended downward during the past month.

The consensus estimate has shifted -6.67% due to these changes.

VGM ScoresAt this time, IPG has a poor Growth Score of F, however its Momentum Score is doing a bit better with a D. Charting a somewhat similar path, the stock has a grade of F on the value side, putting it in the fifth quintile for value investors.

Overall, the stock has an aggregate VGM Score of F. If you aren't focused on one strategy, this score is the one you should be interested in.

OutlookEstimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. It's no surprise IPG has a Zacks Rank #4 (Sell). We expect a below average return from the stock in the next few months.